Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
NCT00000584 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2013-11-26
Summary
To evaluate the capacity of intravenously administered cytomegalovirus (CMV)-immune globin (CMVIG) to immunize high risk premature infants against CMV infections.
Conditions
- Blood Transfusion
- Cytomegalovirus Infections
Interventions
- DRUG
-
immunoglobulins
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
Eligibility
- Max Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1983-07-31
- Completion
- 1988-06-30
More Related Trials
-
Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection
NCT04934527 ·Status: COMPLETED ·Phase: PHASE2
-
Infant Immune Response to Bacterial Infection
NCT00546195 ·Status: COMPLETED
-
Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy
NCT02129465 ·Status: UNKNOWN
-
Biomarkers of Cytomegalovirus Fetal Infection and Disease
NCT03090841 ·Status: UNKNOWN
-
Cytomegalovirus (CMV) Infection in Amniotic Fluid
NCT00194142 ·Status: COMPLETED
-
Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients
NCT00699868 ·Status: COMPLETED ·Phase: NA
-
Screening for Congenital Cytomegalovirus Infection in Newborns
NCT02683096 ·Status: COMPLETED
-
Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants
NCT01178905 ·Status: COMPLETED ·Phase: NA
-
Cytomegalovirus (CMV) Infection in Pregnancy
NCT00194155 ·Status: COMPLETED
-
Prenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy
NCT04615715 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Congenital Cytomegalovirus Infection in Newborn With Particular Risk
NCT05754879 ·Status: COMPLETED
-
Development of a Serocorrelate of Protection Against Invasive Group B Streptococcus Disease
NCT04735419 ·Status: RECRUITING
-
A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China
NCT02645396 ·Status: COMPLETED
-
Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
NCT03246230 ·Status: COMPLETED ·Phase: NA
-
Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)
NCT05170269 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection
NCT00881517 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Observational Study of the Management of Infants With Congenital CMV
NCT05855889 ·Status: RECRUITING
-
Priming of the NEonatal Immune System by Transfer of Maternal Immunity
NCT05429047 ·Status: UNKNOWN
-
Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation.
NCT05370976 ·Status: TERMINATED ·Phase: PHASE2
-
A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China
NCT02710864 ·Status: COMPLETED
-
Long-Term Outcomes of Children With Congenital CMV in New York State
NCT06226558 ·Status: RECRUITING
-
Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital
NCT04653948 ·Status: ACTIVE_NOT_RECRUITING
-
Cytomegalovirus (CMV) Transmission by Frozen Breast Milk in Preterms
NCT00668798 ·Status: SUSPENDED
-
The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection
NCT01081379 ·Status: UNKNOWN
-
Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants
NCT00113191 ·Status: COMPLETED ·Phase: NA